参考文献/References:
[1]MARTINEZ FJ,COLLARD HR,PARDO A,et al.Idiopathic pulmonary fibrosis[J].Nat Rev Dis Primers,2017,3:17074.
[2]DEWAGE S,ORGAN L,KOUMOUNDOUROS E,et al.The efficacy of pirfenidone in a sheep model of pulmonary fibrosis[J].Exp Lung Res,2019,45(9-10):310-322.
[3]MAHER TM,STREK ME.Antifibrotic therapy for idiopathic pulmonary fibrosis:time to treat[J].Respir Res,2019,20(1):205.
[4]KING TE JR,BRADFORD WZ,CASTRO-BERNARDINI S,et al.Aphase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis[J].N Engl J Med,2014,370(22):2083-2092.
[5]RICHELDI L,KOLB M,JOUNEAU S,et al.Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis[J].BMC Pulm Med,2020,20(1):3.
[6]ANTONIOU KM,TSITOURA E,VASARMIDI E,et al.Precision medicine in idiopathic pulmonary fibrosis therapy:From translational research to patient-centered care[J].Curr Opin Pharmacol,2021,57:71-80.
[7]GRILLO F,BARISIONE E,BALL L,et al.Lung fibrosis:an undervalued finding in COVID-19 pathological series[J].Lancet Infect Dis,2021,21(4):e72.
[8]张耀艺,庞立健.基于肺络病证治体系探讨肺纤维化不同阶段的病机转变[J].中医药临床杂志,2022,34(4):603-607.
[9]MURPHY BS,BUSH HM,SUNDARESHAN V,et al.Characterization of macrophage activation states in patients with cystic fibrosis[J].J Cyst Fibros,2010,9(5):314-322.
[10]FURUHASHI K,SUDA T,NAKAMURA Y,et al.Increased expression of YKL-40,a chitinase-like protein,in serum and lung of patients with idiopathic pulmonary fibrosis[J].Respir Med,2010,104(8):1204-1210.
[11]孟令鑫,李浩源,刘建,等.王玉光教授分病论治间质性肺疾病[J].西部中医药,2023,36(10):56-59.
[12]滑振,吕晓东,庞立健,等.中医药防治肺纤维化相关文献的数据挖掘[J].中华中医药学刊,2017,35(10):2604-2607.
[13]赵鹏飞,浦明之.叶天士治疗肺痹经验探析[J].中医临床研究,2021,13(13):45-47.
[14]李红梅,张旭辉.中西医治疗特发性肺纤维化的研究进展[J].中医研究,2022,35(3):72-76.
[15]LIU G,ZHAI H,ZHANG T,et al.New therapeutic strategies for IPF:Based on the “phagocytosis-secretion-immunization” network regulation mechanism of pulmonary macrophages[J].Biomed Pharmacother,2019,OCT:118:109230.
[16]DONG J,MA Q.Macrophage polarization and activation at the interface of multi-walled carbon nanotube-induced pulmonary inflammation and fibrosis[J].Nanotoxicology,2018,12(2):153-168.
[17]SHAPOURI-MOGHADDAM A,MOHAMMADIAN S,VAZINI H,et al.Macrophage plasticity,polarization,and function in health and disease[J].J Cell Physiol,2018,233(9):6425-6440.
[18]GIBBONS MA,MACKINNON AC,RAMACHANDRAN P,et al.Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis[J].Am J Respir Crit Care Med,2011,184(5):569-581.
[19]SONI S,WILSON MR,O’,et al.Alveolar macrophage-derived microvesicles mediate acute lung injury[J].Thorax,2016,71(11):1020-1029.
[20]GARBI N,LAMBRECHT BN.Location,function,and ontogeny of pulmonary macrophages during the steady state[J].Pflugers Arch,2017,469(3-4):561-572.
[21]YUNNA C,MENGRU H,LEI W,et al.Macrophage M1/M2 polarization[J].Eur J Pharmacol,2020,877:173090.
[22]CHENG P,LI S,CHEN H.Macrophages in Lung Injury,Repair,and Fibrosis[J].Cells,2021,10(2):436.
[23]WANG Y,ZHANG L,WU GR,et al.MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program[J].Sci Adv,2021,7(1):eabb6075.
[24]LI D,GUABIRABA R,BESNARD AG,et al.IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.J Allergy Clin Immunol.2014.134(6):1422-1432.
[25]LANG R,RUTSCHMAN RL,GREAVES DR,et al.Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter[J].J Immunol,2002,168(7):3402-3411.
[26]DUKE KS,BONNER JC.Mechanisms of carbon nanotube-induced pulmonary fibrosis:a physicochemical characteristic perspective[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2018,10(3):e1498.
[27]MEZIANI L,MONDINI M,PETIT B,et al.CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages[J].Eur Respir J,2018,51(3):1702120.
[28]MURTHY S,LARSON-CASEY JL,RYAN AJ,et al.Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor,macrophage receptor with collagenous structure[J].FASEB J,2015,29(8):3527-3536.
[29]RSZER T.Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms[J].Mediators Inflamm,2015,2015:816460.
[30]韩李念,陈旭林.巨噬细胞在急性肺损伤的作用.中华损伤与修复杂志(电子版).2016.11(4):294-297.
[31]唐心浩,储博文,秦媛媛,等.从“三焦-营卫”气化失常角度探析肿瘤T细胞耗竭机制[J].中国实验方剂学杂志,2024,30(5):176-185.
[32]DE LAS CASAS-ENGEL M,CORB AL.Serotonin modulation of macrophage polarization:inflammation and beyond[J].Adv Exp Med Biol,2014,824:89-115.
[33]赵保胜,霍海如,李兰芳,等.桂枝汤对小鼠巨噬细胞株分泌炎症因子的影响[J].中国实验方剂学杂志,2006,12(10):23-25.
相似文献/References:
[1]多杰卓玛 黄燕烽 梅之南 周生军 彭逸 陈维武.二十五味珍珠片抗PM2.5作用及机制的探究[J].现代中医药,2022,1(03):043.[doi:10.13424/j.cnki.mtcm.2022.03.008]
DUO Jiezhuoma HUANG Yanfeng MEI Zhinan ZHOU Shengjun PENG Yi CHEN Weiwu.Research of Twenty Five Flavor Pearl Tablet Function and Mechanism on Anti PM2.5[J].Modern Traditional Chinese Medicine,2022,1(05):043.[doi:10.13424/j.cnki.mtcm.2022.03.008]